Covid-19 symptoms in seniors/different?

[Yuck]

cnn.com/2020/04/23/health/s...

~ Yuck

[Newdawn Administrator]

I’m wondering if any effective vaccine might be given to those in the vulnerable groups first or whether they’d be a more fiscal focus on getting the younger and fitter ‘immune’ and back to productivity.

Newdawn

[Yuck in reply to Newdawn]

I understand from my latest zoom presentation with Brian Kauffman and the CLL society guest presenters on April 13 that there is very little data about CLLers as they are cautious types and not catching the virus. Additionally, presenters said over 60 potential vaccines are now being studied. There is no “data” yet on humans getting vaccinated.

The majority of vaccines being studied are inactive (not live). Currently vaccines are only being studied in “healthy” patients.

There is no data on CLLers being immune after recovering from Covid-19.

So to sum up, it’s too early to know if a vaccine will work on anyone. Different vaccines have different abilities to help patients. Some vaccines work less well or not at all in cancer patients. We do not know if CLLers will make antibodies from a vaccine.

These remarks are from my notes and reflect the comments of 3 presenters who were responding to questions previously submitted by CLLers.

Thank you to Brian for arranging these presentations via zoom!

~ Yuck

[wmay13241 in reply to Yuck]

How well would a non-live vaccine work for someone with an IgG below 400?

[Yuck]

My notes from April 3:

A doctor said science does not know if IgG is protective.

Notes from April 17:

A doctor said there is very little data on how a CLL patient with Covid-19 should be managed. Should they get IgG or be managed differently?

Also, in that session, it was mentioned that maybe science could make “synthetic” Covid antibodies for a treatment.

Plasma with antibodies from recovered Covid patients could be a treatment.

Hope this helps!

I am not in the medical field.

~ Yuck